Hydrocortisone for Term Hypotension

Completed · Phase 3 · Has a placebo group

Conditions studied: Infant, Newborn, Diseases, Cardiovascular Insufficiency

In brief

This trial will evaluate the effects of a 7-day course of hydrocortisone therapy on short-term morbidity, cardiovascular function, long-term neurodevelopment, and mortality in critically ill, term and late preterm infants diagnosed with cardiovascular insufficiency as defined by a need for inotrope therapy in the first 72 hours of age.

Key facts

Study ID
NCT01954056
Run by
NICHD Neonatal Research Network
People needed
12
Starts
2014-06-19
Expected to finish
2018-03-20
Last updated by the study team
2021-07-06

Who can join

Age: 1 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.